Enhanced Drug Delivery by Dissolution of Amorphous Drug Encapsulated in a Water Unstable Metal–Organic Framework (MOF)

Encapsulating a drug molecule into a water‐reactive metal–organic framework (MOF) leads to amorphous drug confined within the nanoscale pores. Rapid release of drug occurs upon hydrolytic decomposition of MOF in dissolution media. Application to improve dissolution and solubility for the hydrophobic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie (International ed.) Jg. 58; H. 47; S. 16790 - 16794
Hauptverfasser: Suresh, Kuthuru, Matzger, Adam J.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Germany Wiley Subscription Services, Inc 18.11.2019
Wiley Blackwell (John Wiley & Sons)
Ausgabe:International ed. in English
Schlagworte:
amorphous drug
Collapse
Crystallization
Curcumin
Dissolution
Drug delivery
Drug delivery systems
Encapsulation
Hydrophobicity
immediate drug release
Metal-organic frameworks
metal–organic framework
stability
Sulindac
Supersaturation
amorphous drug
drug delivery
immediate drug release
stability
metal-organic framework
ISSN:1433-7851, 1521-3773, 1521-3773
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Encapsulating a drug molecule into a water‐reactive metal–organic framework (MOF) leads to amorphous drug confined within the nanoscale pores. Rapid release of drug occurs upon hydrolytic decomposition of MOF in dissolution media. Application to improve dissolution and solubility for the hydrophobic small drug molecules curcumin, sulindac, and triamterene is demonstrated. The drug@MOF composites exhibit significantly enhanced dissolution and achieves high supersaturation in simulated gastric and/or phosphate buffer saline media. This combination strategy where MOF inhibits crystallization of the amorphous phase and then releases drug upon MOF irreversible structural collapse represents a novel and generalizable approach for drug delivery of poorly soluble compounds while overcoming the traditional weakness of amorphous drug delivery: physical instability of the amorphous form. MOF carrier: A drug delivery strategy where a metal–organic framework inhibits crystallization of the amorphous drug phase and then releases the drug upon hydrolytic decomposition represents a novel approach for delivery of poorly soluble compounds while overcoming the traditional weakness of amorphous drug delivery: physical instability of the amorphous form.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
USDOE
SC0004888
ISSN:1433-7851
1521-3773
1521-3773
DOI:10.1002/anie.201907652